391 results on '"Aubert, Sébastien"'
Search Results
2. Automatically Learning Fallback Strategies with Model-Free Reinforcement Learning in Safety-Critical Driving Scenarios
3. Surgical treatment outcomes of solitary fibrous tumors in the head and neck: A retrospective study
4. D’une gestion optimale des échantillons osseux à une prise en charge de qualité des malades en 2022 : un nouveau paradigme
5. YAP1-TFE3-fused hemangioendothelioma: a multi-institutional clinicopathologic study of 24 genetically-confirmed cases
6. A large extended family with hyperparathyroidism-jaw tumor syndrome due to deletion of the third exon of CDC73: clinical and molecular features
7. Novel partners of USP6 gene in a spectrum of bone and soft tissue lesions
8. Tumeurs de l’articulation temporomandibulaire – revue de la littérature
9. NFATc2-rearranged sarcomas: clinicopathologic, molecular, and cytogenetic study of 7 cases with evidence of AGGRECAN as a novel diagnostic marker
10. Effect of decalcification protocols on immunohistochemistry and molecular analyses of bone samples
11. Recurrent novel THBS1-ADGRF5 gene fusion in a new tumor subtype “Acral FibroChondroMyxoid Tumors”
12. Calcium channel ITPR2 and mitochondria–ER contacts promote cellular senescence and aging
13. Évaluation des marges de résection des sarcomes osseux traités par chimiothérapie néoadjuvante : revue de la littérature et recommandations du Groupe OS (GROUPOS) du Groupe Sarcome français et du Groupe d’étude des tumeurs osseuses (GSF-GETO/RESOS)
14. Assessment of resection margins in bone sarcoma treated by neoadjuvant chemotherapy: Literature review and guidelines of the bone group (GROUPOS) of the French sarcoma group and bone tumor study group (GSF-GETO/RESOS)
15. Revisiting the role of the pathological grading in pediatric adrenal cortical tumors: results from a national cohort study with pathological review
16. Parallel QR decomposition in LTE-A systems
17. PLA2R1 promotes DNA damage and inhibits spontaneous tumor formation during aging
18. Diagnostic des lésions osseuses riches en cellules géantes : démarche diagnostique et intérêt des nouvelles techniques complémentaires immuno-histochimiques et moléculaires
19. Clinicopathological description of 43 oncocytic adrenocortical tumors: importance of Ki-67 in histoprognostic evaluation
20. Prevalence of Endocrine Manifestations and GIST in 108 Systematically Screened Patients With Neurofibromatosis Type 1
21. Surgical treatment outcomes of solitary fibrous tumors in the head and neck: A retrospective study
22. H3F3 mutation status of giant cell tumors of the bone, chondroblastomas and their mimics: a combined high resolution melting and pyrosequencing approach
23. Denosumab-treated Giant Cell Tumors of Bone: A Clinicopathologic Analysis of 35 Cases From the French Group of Bone Pathology
24. Large sporadic thyroid medullary carcinomas: predictive factors for lymph node involvement
25. Supplementary Figure 6 from Potassium Channel KCNA1 Modulates Oncogene-Induced Senescence and Transformation
26. Supplementary Figure Legends 1-3 from MUC1, a New Hypoxia Inducible Factor Target Gene, Is an Actor in Clear Renal Cell Carcinoma Tumor Progression
27. Supplementary Figure 9 from Potassium Channel KCNA1 Modulates Oncogene-Induced Senescence and Transformation
28. Data from Potassium Channel KCNA1 Modulates Oncogene-Induced Senescence and Transformation
29. Supplementary Figure 1 from Potassium Channel KCNA1 Modulates Oncogene-Induced Senescence and Transformation
30. Supplementary Figure 7 from Potassium Channel KCNA1 Modulates Oncogene-Induced Senescence and Transformation
31. Supplementary Figure 1 from MUC1, a New Hypoxia Inducible Factor Target Gene, Is an Actor in Clear Renal Cell Carcinoma Tumor Progression
32. Supplementary Figure 3 from MUC1, a New Hypoxia Inducible Factor Target Gene, Is an Actor in Clear Renal Cell Carcinoma Tumor Progression
33. Supplementary Figure Legends from Potassium Channel KCNA1 Modulates Oncogene-Induced Senescence and Transformation
34. Data from MUC1, a New Hypoxia Inducible Factor Target Gene, Is an Actor in Clear Renal Cell Carcinoma Tumor Progression
35. Supplementary Table 1 from MUC1, a New Hypoxia Inducible Factor Target Gene, Is an Actor in Clear Renal Cell Carcinoma Tumor Progression
36. Supplementary Figure 4 from Potassium Channel KCNA1 Modulates Oncogene-Induced Senescence and Transformation
37. Data from PLA2R1 Mediates Tumor Suppression by Activating JAK2
38. Supplementary Figure 2 from MUC1, a New Hypoxia Inducible Factor Target Gene, Is an Actor in Clear Renal Cell Carcinoma Tumor Progression
39. Supplementary Figure 8 from Potassium Channel KCNA1 Modulates Oncogene-Induced Senescence and Transformation
40. Supplementary Figure 2 from Potassium Channel KCNA1 Modulates Oncogene-Induced Senescence and Transformation
41. Supplementary Figure 5 from Potassium Channel KCNA1 Modulates Oncogene-Induced Senescence and Transformation
42. Supplementary Materials and Methods from Potassium Channel KCNA1 Modulates Oncogene-Induced Senescence and Transformation
43. Supplementary Figure 3 from Potassium Channel KCNA1 Modulates Oncogene-Induced Senescence and Transformation
44. Supplementary Table 1, Figures 1 - 8 from PLA2R1 Mediates Tumor Suppression by Activating JAK2
45. Serum succinate/fumarate ratio in paraganglioma/pheochromocytoma patients attending an endocrine oncogenetic unit
46. Characterization of the Tumor Microenvironment in Jaw Osteosarcomas, towards Prognostic Markers and New Therapeutic Targets
47. A new subtype of high-grade mandibular osteosarcoma with RASAL1/MDM2 amplification
48. Integrated molecular characterization of chondrosarcoma reveals critical determinants of disease progression
49. Systematic thyroid screening in myotonic dystrophy: link between thyroid volume and insulin resistance
50. Serum Succinate/Fumarate Ratio in Patients With Paraganglioma/Pheochromocytoma Attending an Endocrine Oncogenetic Unit.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.